In the human genome, the majority of protein-encoding genes are interrupted by introns, which are removed from primary transcripts by a macromolecular enzyme known as the spliceosome. Spliceosomes can constitutively remove all the introns in a primary transcript to yield a fully spliced mRNA or alternatively splice primary transcripts leading to the production of many different mRNAs from one gene. This review examines how spliceosomes can recombine two primary transcripts in trans to reprogram messenger RNAs.
Mariano A. Garcia-Blanco
Title and authors | Publication | Year |
---|---|---|
α1-Antitrypsin Deficiency
D Perlmutter |
Zakim and Boyer s Hepatology | 2012 |
IL-7 splicing variant IL-7δ5 induces human breast cancer cell proliferation via activation of PI3K/Akt pathway
D Pan, B Liu, X Jin, J Zhu |
Biochemical and Biophysical Research Communications | 2012 |